Menjugate vaccine recall in the UK attracts widespread publicity
This article was originally published in Scrip
Executive Summary
Novartis has recalled two batches of the meningitis vaccine, Menjugate Kit (meningococcal group C conjugate vaccine) in the UK as a precautionary measure. A sterility failure in a batch of solvent used in the vaccines was found during non-routine testing. The UK regulator, the MHRA, has instituted a class 2 alert, with action to be taken within 48 hours.